Cargando…
Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
BACKGROUND: Despite universal prophylaxis, late cytomegalovirus (CMV) infection occurs in a high proportion of kidney transplant recipients. We evaluated whether a specific viral T-cell response allows for the better identification of recipients who are at high risk of CMV infection after prophylaxi...
Autores principales: | Deborska-Materkowska, Dominika, Perkowska-Ptasinska, Agnieszka, Sadowska, Anna, Gozdowska, Jolanta, Ciszek, Michał, Serwanska-Swietek, Marta, Domagala, Piotr, Miszewska-Szyszkowska, Dorota, Sitarek, Elzbieta, Jozwik, Agnieszka, Kwiatkowski, Artur, Durlik, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902940/ https://www.ncbi.nlm.nih.gov/pubmed/29661141 http://dx.doi.org/10.1186/s12879-018-3075-z |
Ejemplares similares
-
Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019) -
QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country
por: Pongsakornkullachart, Kritsada, et al.
Publicado: (2022) -
Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
por: Kadkhoda, Kamran, et al.
Publicado: (2023) -
Urinary MicroRNA-21-5p as Potential Biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Kidney Transplant Recipients
por: Gniewkiewicz, Michal S., et al.
Publicado: (2020) -
Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)